Tolfenamic Acid

Tolfenamic Acid

SCHEMBL28095333

CCC(=O)O.Cc1c(Cl)cccc1Nc1ccccc1C(=O)O

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 9/20 0.86
PTGS2 P35354 5/20 0.86
MEN1 O00255 3/20 0.86
AKR1C3 P42330 3/20 0.86
KMT2A Q03164 3/20 0.86
LMNA P02545 2/20 0.86
CYP1A2 P05177 2/20 0.86
CYP3A4 P08684 2/20 0.86
CYP2C9 P11712 2/20 0.86
HIF1A Q16665 2/20 0.86
TTR P02766 2/20 0.86
ADORA3 P0DMS8 2/20 0.86
USP2 O75604 1/20 0.86
PLA2G1B P04054 1/20 0.86
PGR P06401 1/20 0.86
HTR1A P08908 1/20 0.86
ADRA2A P08913 1/20 0.86
AR P10275 1/20 0.86
MAPT P10636 1/20 0.86
HPGD P15428 1/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tolfenamic Acid SCHEMBL25190 0.93 MT-CO2 (1.00) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL29484181 0.93 MT-CO2 (1.00) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL8060884 0.93 MT-CO2 (1.00) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL29389998 0.93 MT-CO2 (1.00) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL27540385 0.91 MT-CO2 (0.97) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL10619715 0.87 MT-CO2 (0.89) MT-CO2PTGS2MEN1AKR1C3KMT2A
SCHEMBL10031550 0.86 MT-CO2 (0.71) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL17782154 0.84 MT-CO2 (0.72) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL28229025 0.84 MT-CO2 (0.82) MT-CO2PTGS2MEN1AKR1C3KMT2A
Tolfenamic Acid SCHEMBL14976730 0.84 MT-CO2 (0.82) MT-CO2PTGS2MEN1AKR1C3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105848680-A Treatment using bruton's tyrosine kinase inhibitors and immunotherapy 药品循环有限责任公司 2016-08-10 CN disclosed